Evidence map›Paper›PMID 38662766›Full record

ArticleBrain : a journal of neurology2024

Revisiting distinct nerve excitability patterns in patients with amyotrophic lateral sclerosis.

Diederik J L Stikvoort García, H Stephan Goedee, Ruben P A van Eijk, Leonard J van Schelven, Leonard H van den Berg, Boudewijn T H M Sleutjes

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diederik J L Stikvoort GarcíaDepartment of Neurology, Brain Centre Utrecht, University Medical Centre Utrecht, Utrecht, 3584CX, The Netherlands.ORCID 0000-0003-3984-1635
H Stephan GoedeeDepartment of Neurology, Brain Centre Utrecht, University Medical Centre Utrecht, Utrecht, 3584CX, The Netherlands.
Ruben P A van EijkDepartment of Neurology, Brain Centre Utrecht, University Medical Centre Utrecht, Utrecht, 3584CX, The Netherlands.
Leonard J van SchelvenDepartment of Medical Technology and Clinical Physics, University Medical Centre Utrecht, 3584CX, Utrecht, The Netherlands.
Leonard H van den BergDepartment of Neurology, Brain Centre Utrecht, University Medical Centre Utrecht, Utrecht, 3584CX, The Netherlands.
Boudewijn T H M SleutjesDepartment of Neurology, Brain Centre Utrecht, University Medical Centre Utrecht, Utrecht, 3584CX, The Netherlands.ORCID 0000-0001-6618-3573
Utrecht University · NLUniversity Medical Center Utrecht · NL

Funding

Dutch ALS Foundation AV20180012
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis is a devastating neurodegenerative disease, characterized by loss of central and peripheral motor neurons. Although the disease is clinically and genetically heterogeneous, axonal hyperexcitability is a commonly observed feature that has been suggested to reflect an early pathophysiological step linked to the neurodegenerative cascade. Therefore, it is important to clarify the mechanisms causing axonal hyperexcitability and how these relate to the clinical characteristics of patients. Measures derived directly from a nerve excitability recording are frequently used as study end points, although their biophysical basis is difficult to deduce. Mathematical models can aid in the interpretation but are reliable only when applied to group-averaged recordings. Consequently, model estimates of membrane properties cannot be compared with clinical characteristics or treatment effects in individual patients, posing a considerable limitation in heterogeneous diseases, such as amyotrophic lateral sclerosis. To address these challenges, we revisited nerve excitability using a new pattern analysis-based approach (principal component analysis). We evaluated disease-specific patterns of excitability changes and established their biophysical origins. Based on the observed patterns, we developed new compound measures of excitability that facilitate the implementation of this approach in clinical settings. We found that excitability changes in amyotrophic lateral sclerosis patients (n = 161, median disease duration = 11 months) were characterized by four unique patterns compared with controls (n = 50, age and sex matched). These four patterns were best explained by changes in resting membrane potential (modulated by Na+/K+ currents), slow potassium and sodium currents (modulated by their gating kinetics) and refractory properties of the nerve. Consequently, we were able to show that altered gating of slow potassium channels was associated with, and predictive of, the rate of progression of the disease on the amyotrophic lateral sclerosis functional rating scale. Based on these findings, we designed four composite measures that capture these properties to facilitate implementation outside this study. Our findings demonstrate that changes in nerve excitability in patients with amyotrophic lateral sclerosis are dominated by four distinct patterns, each with a distinct biophysical origin. Based on this new approach, we provide evidence that altered slow potassium-channel function might play a role in the rate of disease progression. The magnitudes of these patterns, quantified using a similar approach or our new composite measures, have potential as efficient measures to study membrane properties directly in amyotrophic lateral sclerosis patients, and thus aid prognostic stratification and trial design.

Indexed as

Amyotrophic Lateral SclerosisMotor NeuronsAction PotentialsAdultAgedAxonsFemaleHumansMaleMembrane PotentialsMiddle AgedPrincipal Component Analysisamyotrophic lateral sclerosiscomposite measuresEMGion channelsnerve excitabilityprogression rate

Identifiers

PMID38662766
PMCPMC11491535
OpenAlexW4395448041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.